Prostate News Archive
14-Jun-2011
Prostate cancer drug's painful price
Provenge is a prostate cancer drug that works by using the patients' own cells. It is a medical breakthrough, with litte or no side effects for patients. But the sky-high cost of it is raising some tough questions about whether taxpayers should be footing the bill. Deepak Chopra: Weekly Health Tip: Prostate Cancer -- To Screen or Not to Screen?
Still, in its aggressive form, prostate cancer is serious business: It kills 30,000 men each year in the U.S. and is the second most common cause of cancer death among men (after lung cancer). Prostate cancer drugs may extend survival
prostate cancer is the most common cancer in men, looming as a specter for many as they grow older. So far, this week's headlines about prostate cancer research have been fairly positive, with results from two trials showing promise for extending survival among men with late-stage forms of the cancer. Here?s a look at the latest developments:
Back to Prostate News Archive
